PUMA's Q2 Beat Didn't Save the Story: 9.4% Sales Drop Keeps the Stock on Trial

Better margins and cash flow did not offset the sales miss

PUMA's quarter looked better in the numbers than in the market reaction. Management delivered a smaller-than-expected loss and slightly better revenue than expected, but investors focused on the harder truth at the top line: 9.4% currency-adjusted sales decline to €1,690.6 million. That helps explain why the stock fell 3.16% in premarket trading despite the apparent beat.

The debate is straightforward. Bulls can argue PUMA is imposing better discipline on a messy business. Bears can argue the beat was mostly cosmetic because core demand is still weak. The clearest reading is in between: the quarter was cleaner than feared, but it was not yet a sign of genuine recovery.

Margin improvement and working-capital gains improved the ledger

PUMA's gross profit margin improved to 48.0%, up 180 basis points from a year ago. Management attributed part of that gain to lower sourcing prices, tariff refunds, and a more favorable channel mix. Those are real operating benefits, but they are not the same thing as stronger customer demand.

Profitability also looked less bad. Reported EBIT improved to €-53.1 million from €-109.1 million a year earlier, while adjusted EBIT excluding one-offs was €-41.9 million. Free cash flow was arguably the cleanest part of the report, reaching €328.8 million thanks to better working capital management and lower CAPEX. Inventory pressure also eased, with inventories down 15.3%. That is solid housekeeping. It buys time, even if it does not create demand.

Regional weakness still limits the positive read-through

The geographic picture remains uneven. Asia/Pacific grew 8.6%, while EMEA and the Americas were down double digits, according to the cited release data. That suggests the brand is not broken everywhere, but the weakness in larger regions is still too broad to call this a full consumer rebound.

There are at least a few constructive notes inside the business. Management highlighted progress in running and hybrid training, which could matter if those categories continue to gain share. For now, though, they appear to be offsetting weakness rather than fully driving growth.

Cash flow buys time, but the growth story still hinges on 2027

The quarter matters because PUMA has improved its breathing room without proving a full turnaround.

Balance-sheet headroom is real

With free cash flow of €328.8 million, net debt of €1,103.9 million, and sufficient headroom from cash and credit lines, PUMA does not face an immediate funding emergency. That gives management more time to stabilize product, distribution, and demand.

That said, the trade-off is clear. Full-year 2026 is still expected to deliver currency-adjusted sales expected to decline low- to mid-single digits, while leadership said 2027 is expected to be the year of return to growth. In other words, the financial house is getting cleaner, but the consumer recovery still has to arrive.

Execution credibility is improving

PUMA also has a fresher execution layer in place. The company said management transition included senior leadership changes and the appointment of Mark Langer as CFO effective May 2026. That does not solve the demand problem, but it does strengthen the case that the rebuild is being run more tightly.

What would make the turnaround more convincing

The next quarter needs to show more than better cost control. After a three-year transformation program, investors need evidence that PUMA's reset is starting to win back customers, not just improve the statements.

What bulls need to see

• Sales decline narrowing materially from the current 9.4% pace
• More balanced regional performance, not continued double-digit weakness in EMEA and the Americas
• Evidence that margin gains are supported by healthier product demand rather than input-cost benefits alone

What would weaken the story

• Another quarter of weak demand outside Asia/Pacific
• Continued reliance on tariff benefits, sourcing gains, and working-capital improvements to carry the report
• A growing gap between the current sales reset and the hope that 2027 finally brings growth

For now, the cleanest stance is simple: PUMA is a patience test, not a confirmed turnaround.